DARC on RBC limits lung injury by balancing compartmental distribution of CXC chemokines

European Journal of Immunology

Volumn 39, Issue 6, 2009, Pages 1597-1607

  Reutershan, Jörg ^a,b   Harry, Brian ^b   Chang, Daniel ^b   Bagby, Gregory J ^c   Ley, Klaus ^b,d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF VIRGINIA   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Acute lung injury; Chemokines; Inflammation; Polymorphonuclear leukocytes; Transmigration

Indexed keywords

ALPHA CHEMOKINE; BLOOD GROUP ANTIGEN; CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; DUFFY ANTIGEN RECEPTOR FOR CHEMOKINES; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; CXCL1 PROTEIN, MOUSE; CXCL2 PROTEIN, MOUSE; DFY PROTEIN, MOUSE;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL COMPARTMENTALIZATION; CELL MEMBRANE PERMEABILITY; CELL TRANSPORT; CONTROLLED STUDY; ENDOTHELIUM CELL; ERYTHROCYTE; HEMATOPOIETIC CELL; LUNG ALVEOLUS; LUNG INTERSTITIUM; LYMPHOCYTE MIGRATION; MALE; MICROVASCULARIZATION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; REGULATORY MECHANISM; RESPIRATORY TRACT INFLAMMATION; WILD TYPE; ANIMAL; BLOOD; BLOOD GROUP DUFFY SYSTEM; C57BL MOUSE; CAPILLARY PERMEABILITY; CELL MOTION; CHEMISTRY; CHIMERA; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; GENETICS; INHALATIONAL DRUG ADMINISTRATION; LUNG; LUNG LAVAGE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ACUTE LUNG INJURY; ADMINISTRATION, INHALATION; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CAPILLARY PERMEABILITY; CELL MOVEMENT; CHEMOKINE CXCL1; CHEMOKINE CXCL2; CHEMOKINES, CXC; CHIMERA; DISEASE MODELS, ANIMAL; DUFFY BLOOD-GROUP SYSTEM; ENDOTHELIUM, VASCULAR; ERYTHROCYTES; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; RECEPTORS, CELL SURFACE;

EID: 67649509609     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200839089     Document Type: Article

References (60)

1. Rubenfeld, G. D., Caldwell, E., Peabody, E., Weaver, J., Martin, D. P., Neff, M., Stern, E. J., and Hudson, L. D., Incidence and outcomes of acute lung injury. N. Engl. J. Med. 2005. 353: 1685-1693.
2. Azoulay, E., Darmon, M., Delclaux, C., Fieux, F., Bornstain, C., Moreau, D., Attalah, H. et al., Deterioration of previous acute lung injury during neutropenia recovery. Crit. Care Med. 2002. 30: 781-786.
3. Baughman, R. P., Gunther, K. L., Rashkin, M. C., Keeton, D. A. and Pattishall, E. N., Changes in the inflammatory response of the lung during acute respiratory distress syndrome: Prognostic indicators. Am. J. Respir. Crit. Care Med. 1996. 154: 76-81.
4. Abraham, E., Carmody, A., Shenkar, R. and Arcaroli, J., Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000. 279: L1137-L1145.
5. Moser, B., Wolf, M., Walz, A. and Loetscher, P., Chemokines: multiple levels of leukocyte migration control. Trends Immunol. 2004. 25: 75-84.
6. Rot, A. and Von Andrian, U. H., Chemokines in Innate and Adaptive Host Defense: Basic Chemokinese Grammar for Immune Cells. Annu. Rev. Immunol. 2004. 22: 891-928.
7. Neptune, E. R. and Bourne, H. R., Receptors induce chemotaxis by releasing the betagamma subunit of Gi, not by activating Gq or Gs. Proc. Natl. Acad. Sci. USA 1997. 94: 14489-14494.
8. Wu, D., LaRosa, G. J. and Simon, M. I., G protein-coupled signal transduction pathways for interleukin-8. Science 1993. 261: 101-103.
9. Belperio, J. A., Keane, M. P., Burdick, M. D., Londhe, V., Xue, Y. Y., Li, K., Phillips, R. J., and Strieter, R. M., Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J. Clin. Invest. 2002. 110: 1703-1716.
10. Lomas-Neira, J. L., Chung, C. S., Wesche, D. E., Perl, M. and Ayala, A., In vivo gene silencing (with siRNA) of pulmonary expression of MIP-2 versus KC results in divergent effects on hemorrhage-induced, neutrophil-mediated septic acute lung injury. J. Leukoc. Biol. 2005. 77: 846-853.
11. Sue, R. D., Belperio, J. A., Burdick, M. D., Murray, L. A., Xue, Y. Y., Dy, M. C., Kwon, J. J. et al., CXCR2 is critical to hyperoxia-induced lung injury. J. Immunol. 2004. 172: 3860-3868.
12. Vanderbilt, J. N., Mager, E. M., Allen, L., Sawa, T., Wiener-Kronish, J., Gonzalez, R. and Dobbs, L. G., CXC chemokines and their receptors are expressed in type II cells and upregulated following lung injury. Am. J. Respir. Cell. Mol. Biol. 2003. 29: 661-668.
13. Gazoni, L. M., Tribble, C. G., Zhao, M. Q., Unger, E. B., Farrar, R. A., Ellman, P. I., Fernandez, L. G. et al., Pulmonary macrophage inhibition and inhaled nitric oxide attenuate lung ischemia-reperfusion injury. Ann. Thorac. Surg. 2007. 84: 247-253.
14. Maus, U. A., Koay, M. A., Delbeck, T., Mack, M., Ermert, M., Ermert, L., Blackwell, T. S. et al., Role of resident alveolar macrophages in leukocyte traffic into the alveolar air space of intact mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002. 282: L1245-L1252.
15. Mehrad, B., Wiekowski, M., Morrison, B. E., Chen, S. C., Coronel, E. C., Manfra, D. J. and Lira, S. A., Transient lung-specific expression of the chemokine KC improves outcome in invasive aspergillosis. Am. J. Respir. Crit. Care Med. 2002. 166: 1263-1268.
16. Quinton, L. J., Nelson, S., Zhang, P., Boe, D. M., Happel, K. I., Pan, W. H. and Bagby, G. J., Selective transport of cytokine-induced neutrophil chemoattractant from the lung to the blood facilitates pulmonary neutrophil recruitment. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004. 286: L465-L472.
17. Mueller, G. A., Quinlan, W. M., Doyle, N. A. and Doerschuk, C. M., The role of cytoskeletal proteins in neutrophil emigration during pneumonia in rabbits. Am. J. Respir. Crit. Care Med. 1994. 150: 455-461.
18. Pallister, I., Dent, C. and Topley, N., Increased neutrophil migratory activity after major trauma: A factor in the etiology of acute respiratory distress syndrome? Crit. Care Med. 2002. 30: 1717-1721.
19. Reutershan, J., Morris, M. A., Burcin, T. L., Smith, D. F., Chang, D., Saprito, M. S. and Ley, K., Critical role of endothelial CXCR2 in LPSinduced neutrophil migration into the lung. J. Clin. Invest. 2006. 116: 695-702.
20. Grimberg, B. T., Udomsangpetch, R., Xainli, J., McHenry, A., Panichakul, T., Sattabongkot, J., Cui, L. et al., Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med. 2007. 4: E337.
21. Pruenster, M., Mudde, L., Bombosi, P., Dimitrova, S., Zsak, M., Middleton, J., Richmond, A. et al., The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat. Immunol. 2009. 10: 101-108.
22. Pruenster, M. and Rot, A., Throwing light on DARC. Biochem. Soc. Trans. 2006. 34: 1005-1008.
23. He, W., Neil, S., Kulkarni, H., Wright, E., Agan, B. K., Marconi, V. C., Dolan, M. J. et al., Duffy antigen receptor for chemokines mediates transinfection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. Cell Host Microbe 2008. 4: 52-62.
24. Horuk, R., Darbonne, W. C., Hadley, T. J. and Miller, L. H., A receptor for the malarial parasite Plasmodium vivax: The erythrocyte chemokine receptor. Science 1993. 261: 1182-1184.
25. Dawson, T. C., Lentsch, A. B., Wang, Z., Cowhig, J. E., Rot, A., Maeda, N. and Peiper, S. C., Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood 2000. 96: 1681-1684.
26. Luo, H., Chaudhuri, A., Zbrzezna, V., He, Y. and Pogo, A. O., Deletion of the murine Duffy gene (Dfy) reveals that the Duffy receptor is functionally redundant. Mol. Cell. Biol. 2000. 20: 3097-3101.
27. Du, J., Luan, J., Liu, H., Daniel, T. O., Peiper, S., Chen, T. S., Yu, Y. et al., Potential role for Duffy antigen chemokine-binding protein in angiogenesis and maintenance of homeostasis in response to stress. J. Leukoc. Biol. 2002. 71: 141-153.
28. Xu, L., Ashkenazi, A. and Chaudhuri, A., Duffy antigen/receptor for chemokines (DARC) attenuates angiogenesis by causing senescence in endothelial cells. Angiogenesis 2007. 10: 307-318.
29. Middleton, J., Neil, S., Wintle, J., Clark-Lewis, I., Moore, H., Lam, C., Auer, M. et al., Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 1997. 91: 385-395.
30. Lee, J. S., Frevert, C.W., Wurfel, M. M., Peiper, S. C., Wong, V. A., Ballman, K. K., Ruzinski, J. T. et al., Duffy antigen facilitatesmovement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo. J. Immunol. 2003. 170: 5244-5251.
31. Bruhl, H., Vielhauer, V., Weiss, M., Mack, M., Schlondorff, D. and Segerer, S., Expression of DARC, CXCR3 and CCR5 in giant cell arteritis. Rheumatology (Oxford) 2005. 44: 309-313.
32. Patterson, A. M., Siddall, H., Chamberlain, G., Gardner, L. and Middleton, J., Expression of the duffy antigen/receptor for chemokines (DARC) by the inflamed synovial endothelium. J. Pathol. 2002. 197: 108-116.
33. Segerer, S., Regele, H., Mack, M., Kain, R., Cartron, J. P., Colin, Y., Kerjaschki, D. and Schlondorff, D., The Duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis. Kidney Int. 2000. 58: 1546-1556.
34. Hadley, T. J. and Peiper, S. C., From malaria to chemokine receptor: The emerging physiologic role of the Duffy blood group antigen. Blood 1997. 89: 3077-3091.
35. Shen, H., Schuster, R., Stringer, K. F., Waltz, S. E. and Lentsch, A. B., The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth. FASEB J. 2006. 20: 59-64.
36. Wang, J., Ou, Z. L., Hou, Y. F., Luo, J. M., Shen, Z. Z., Ding, J. and Shao, Z. M., Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential. Oncogene 2006. 25: 7201-7211.
37. Martin, G. S., Mannino, D. M., Eaton, S., Moss, M., The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 2003. 16: 1546-1554.
38. Ness, R. B., Haggerty, C. L., Harger, G., and Ferrell, R., Differential distribution of allelic variants in cytokine genes among African Americans and White Americans. Am. J. Epidemiol. 2004. 160: 1033-1038.
39. Reid, C. L., Perrey, C., Pravica, V., Hutchinson, I. V. and Campbell, I. T., Genetic variation in proinflammatory and anti-inflammatory cytokine production in multiple organ dysfunction syndrome. Crit. Care Med. 2002. 30: 2216-2221.
40. Mayr, F. B., Spiel, A. O., Leitner, J. M., Firbas, C., Kliegel, T., JilmaStohlawetz, P., Derendorf, H. and Jilma, B., Duffy antigen modifies the chemokine response in human endotoxemia. Crit. Care Med. 2008. 36: 159-165.
41. Darbonne, W. C., Rice, G. C., Mohler, M. A., Apple, T., Hebert, C. A., Valente, A. J. and Baker, J. B., Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J. Clin. Invest. 1991. 88: 1362-1369.
42. Zarbock, A., Schmolke, M., Bockhorn, S. G., Scharte, M., Buschmann, K., Ley, K. and Singbartl, K., The Duffy antigen receptor for chemokines in acute renal failure: A facilitator of renal chemokine presentation. Crit. Care Med. 2007. 35: 2156-2163.
43. Lee, J. S., Wurfel, M. M., Matute-Bello, G., Frevert, C.W., Rosengart, M. R., Ranganathan, M., Wong, V. W. et al., The Duffy antigen modifies systemic and local tissue chemokine responses following lipopolysaccharide stimulation. J. Immunol. 2006. 177: 8086-8094.
44. Fukuma, N., Akimitsu, N., Hamamoto, H., Kusuhara, H., Sugiyama, Y. and Sekimizu, K., A role of the Duffy antigen for the maintenance of plasma chemokine concentrations. Biochem. Biophys. Res. Commun. 2003. 303: 137-139.
45. De, F. K., Henderson, R. B., Laschinger, M. and Hogg, N., Neutrophil chemokines KC and macrophage-inflammatory protein-2 are newly synthesized by tissue macrophages using distinct TLR signaling pathways. J. Immunol. 2008. 180: 4308-4315.
46. Kasama, T., Miwa, Y., Isozaki, T., Odai, T., Adachi, M. and Kunkel, S. L., Neutrophil-derived cytokines: Potential therapeutic targets in inflammation. Curr. Drug Targets Inflamm. Allergy 2005. 4: 273-279.
47. Scapini, P., Lapinet-Vera, J. A., Gasperini, S., Calzetti, F., Bazzoni, F., and Cassatella, M. A., The neutrophil as a cellular source of chemokines. Immunol. Rev. 2000. 177: 195-203.
48. Middleton, J., Patterson, A. M., Gardner, L., Schmutz, C. and Ashton, B. A., Leukocyte extravasation: Chemokine transport and presentation by the endothelium. Blood 2002. 100: 3853-3860.
49. Eckle, T., Grenz, A., Laucher, S. and Eltzschig, H. K., A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J. Clin. Invest 2008, 118, 3301-3315.
50. Reutershan, J., Vollmer, I., Stark, S., Wagner, R., Ngamsri, K. C. and Eltzschig, H. K., Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. FASEB J. 2008, 23, 473-482.
51. Reutershan, J., Cagnina, R. E., Chang, D., Linden, J. and Ley, K., Therapeutic anti-inflammatory effects ofmyeloid cell adenosine receptor a2a stimulation in lipopolysaccharide-induced lung injury. J. Immunol. 2007. 179: 1254-1263.
52. Murphree, L. J., Sullivan, G. W., Marshall, M. A. and Linden, J., Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: Role of NF-kappaB in A(2A) adenosine receptor induction. Biochem. J. 2005. 391: 575-580.
53. Forlow, S. B., Schurr, J. R., Kolls, J. K., Bagby, G. J., Schwarzenberger, P. O. and Ley, K., Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice. Blood 2001. 98: 3309-3314.
54. Reutershan, J., Basit, A., Galkina, E. V. and Ley, K., Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005. 289: L807-L815.
55. Reutershan, J., Chang, D., Hayes, J. K. and Ley, K., Protective effects of isoflurane pretreatment in endotoxin-induced lung injury. Anesthesiology 2006. 104: 511-517.
56. Green, T. P., Johnson, D. E., Marchessault, R. P. and Gatto, C. W., Transvascular flux and tissue accrual of Evans blue: Effects of endotoxin and histamine. J. Lab Clin. Med. 1988. 111: 173-183.
57. Peng, X., Hassoun, P. M., Sammani, S., McVerry, B. J., Burne, M. J., Rabb, H., Pearse, D. et al., Protective Effects of Sphingosine 1-Phosphate in Murine Endotoxin-induced Inflammatory Lung Injury. Am. J. Respir. Crit. Care Med. 2004. 169: 1245-1251.
58. Wang, L. F., Patel, M., Razavi, H. M., Weicker, S., Joseph, M. G., McCormack, D. G. and Mehta, S., Role of Inducible Nitric Oxide Synthase in Pulmonary Microvascular Protein Leak in Murine Sepsis. Am. J. Respir. Crit. Care Med. 2002. 165: 1634-1639.
59. Kolosova, I. A., Mirzapoiazova, T., Moreno-Vinasco, L., Sammani, S., Garcia, J. G. and Verin, A. D., Protective effect of purinergic agonist ATPgammaS against acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008. 294: L319-L324.
60. Olson, T. S., Singbartl, K. and Ley, K., L-selectin is required for fMLP- but not C5a-induced margination of neutrophils in pulmonary circulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002. 282: R1245-R1252.